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Abstract: Background: Attention-deficit hyperactivity disorder (ADHD) is one of the most common
behavioral disorders in childhood and adolescence associated with relevant psychosocial impair-
ments. The basic pathophysiology of ADHD may be related, at least partly, to a deficit in autonomic
arousal processes, which not only influence core symptoms of the disorder, but may also lead to blood
pressure (BP) deviations due to altered arousal regulation. Objectives: This study examined long-term
changes in BP in children and adolescents with ADHD up to young adulthood. Methods: In children
and adolescents aged between 7 and 17 years at baseline, we compared BP recordings in subjects with
(n = 1219, 11.1%) and without (n = 9741, 88.9%) ADHD over a 10-year follow-up using data from the
nationwide German Health Survey for Children and Adolescents (KiGGS). Propensity score matching
was used to improve the comparability between children in the ADHD and control groups with now
n = 1.190 in each group. Results: The results of these matched samples revealed that study participants
with ADHD showed significantly lower systolic BP (107.6 ± 10.7 mmHg vs. 109.5 ± 10.9 mmHg,
p < 0.001, Cohen’s d = 0.17) and diastolic BP (64.6 ± 7.5 mmHg vs. 65.8 ± 7.4 mmHg, p < 0.001,
Cohen’s d = 0.16) at baseline. In a sensitivity analysis with a smaller (n = 272) and more stringently
diagnosed ADHD group, the significant differences remained stable with somewhat higher Cohen’s
d; i.e., 0.25 and 0.27, respectively. However, these differences did not persist after 10-year follow-up
in a smaller matched longitudinal sub-group (ADHD n = 273; control n = 323), as subjects with
and without ADHD had similar levels of systolic (123.4 ± 10.65 vs. 123.78 ± 11.1 mmHg, p = 0.675,
Cohen’s d = 0.15) and diastolic BP (71.86 ± 6.84 vs. 71.85 ± 7.06 mmHg, p = 0.992, Cohen’s d = 0.16).
Conclusions: At baseline, children and adolescents with ADHD had significantly lower BP (of small
effect sizes) compared to the non-ADHD group, whereas this difference was no longer detectable at
follow-up ten years later. These developmental alterations in BP from adolescence to early adulthood
may reflect changes in the state of autonomic arousal, probably modulating the pathophysiology
of ADHD.
Keywords: ADHD; KiGGS study; arousal; blood pressure; long-term changes; children; young adults
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1. Introduction
Attention-deficit hyperactivity disorder (ADHD) is one of the most common be-
havioral disorders of childhood and adolescence, affecting 5% of school children and
3% of adults [1–3]. Inattentiveness, hyperactivity, and impulsiveness that deviate from
developmental age are typical symptoms of the disorder [4]. In addition to the core symp-
tomatology, comorbid psychiatric disorders can lead to long-term social, educational, and
professional impairments [5]. Genetic factors and early environmental risks, which interact
in a complex way and influence structural and functional brain development, play an
essential role and probably contribute to the high etiological heterogeneity in this neu-
rodevelopmental disorder. In ADHD patients, a total volume reduction of the brain [6,7]
as well as volume reductions in prefrontal areas, the basal ganglia, and the cerebellum
have been described [8–11]. It can be assumed that these structural changes are related to
physiological processes within different cortical as well as subcortical brain circuits and
are responsible for both the profile of clinical symptoms and severity of the disorder [8,12].
Specifically, this study focuses on the subcortical circuits of the autonomic nervous sys-
tem. For example, structural brainstem abnormalities of the substantia nigra in ADHD
and related deviations of autonomic sleep parameters [13] seem to play a role and thus
support the arousal hypothesis in ADHD [14–16], including low subcortical functional
activation. The autonomic nervous system has a fundamental impact on the physiological
and psychological regulation of attention and alertness, which is called arousal [17–21]. The
degree of arousal is controlled by complex interactions between the peripheral and central
nervous system. The latter is reflected in activation patterns of high frequency cortical
oscillations like the theta/beta ratio [22]. From an evolutionary point of view, the ability to
continuously adapt the level of arousal to changing environmental conditions/situations
represents a survival advantage. Different psychiatric disorders can be accompanied by
an impaired arousal regulation. For example, an excessively stable arousal state has been
described in depression [23], whereas unstable arousal states have been observed in bipolar
mania and ADHD [24,25].
Various studies have shown that in ADHD both the peripheral arousal and the cortical
arousal are decreased and unstable [26–28]. However, it is unclear whether disturbed
arousal could be responsible for both impaired blood pressure (BP) regulation and reactive,
compensatory autoregulation of behavior resulting in hyperactivity and sensation seeking.
Negrao et al. investigated heart rate variability and skin conductance level in children with
ADHD, in the presence and absence of stimulant therapy [29]. It was shown that, without
adequate therapy, there was an overactivation of the parasympathetic nervous system and
an underactivation of the sympathetic nervous system. Treatment with methylphenidate
could partially normalize the autonomic imbalance. Investigations on the diurnal variations
of the arousal (measured with heart rate and cortisol) in children with ADHD speak in
favor of such an autonomous imbalance (probably closely connected with a dysregulation
of the locus coeruleus and the reticular network). On the basis of cortisol measurements in
saliva and Holter monitorings of heart rate, not only an overall increased heart rate was
found in ADHD, but also a morning hypo-arousal and an afternoon/night hyper-arousal
in circadian analysis [30–33].
Though a multifactorial etiology is suspected in ADHD [34], in the literature there are
numerous references to an arousal dysregulation, which seems to partly cause or modulate
the symptom constellation in ADHD. Autostimulative overcompensation of an underlying
hypoarousal was described as a compensatory attempt to stabilize brain arousal in ADHD,
which may contribute to the ADHD core symptomatology [25]. Dietrich et al. reported
relationships between peripheral BP regulation, arousal, and cognitive performance in
ADHD [35]. In untreated children with ADHD, usually associated with low BP, this mecha-
nism could therefore be involved in the psychosocial problems linked to this disorder [36].
However, since the existing data on BP regulation in ADHD patients (as a reflection of
autonomic arousal) are scarce and inconclusive, the aim of this study was to investigate the
assumption of a lower BP in ADHD further.
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Using the baseline data of the epidemiological, community-based, observational
German Health Interview and Examination Survey for Children and Adolescents (KiGGS)
survey, we previously reported a significantly lower systolic, diastolic, and mean arterial
BP in children (11–17 years) diagnosed with ADHD as compared to a control group [37].
Furthermore, we demonstrated that the severity of ADHD symptoms was associated with
lower BP recordings in both univariate and multivariate analyses. However, whether this
relationship can be seen also in younger children with ADHD and whether it persists in
young adulthood as time goes by remains open. Using data from the second wave of the
KiGGS study, we tested the hypothesis that lower BP could also be observed longitudinally
in adolescents and young adults with ADHD after a ten-year interval.
2. Materials and Methods
2.1. KiGGS Study Design
Our analysis is based on data from the KiGGS study, a nationwide and representative
survey conducted by the Robert Koch Institute, Berlin, Germany, in several waves. Between
2003 and 2006, representative data on the health status of children and adolescents aged
between 0 and 17 years were collected in the KiGGS baseline survey using a random sample
of n = 17,641 participants in 167 cities and municipalities in Germany [38,39]. In the three-
year study period, the children and adolescents (from the age of 11 years upwards) and
also their parents were interviewed in writing, and computer-assisted medical interviews
and physical examinations (including BP and heart rate) were conducted [40,41]. KiGGS
Wave 1 conducted between 2009 and 2013 also aimed to make statements on the individual
physical, psychological, and social development of children and adolescents [41]. Since
Wave 1 was a pure telephone interview-based data collection and no physical examinations
were carried out, no values for BP and heart rate are available from this period. The data
collection of KiGGS Wave 2 was carried out from 2014 to 2017. The first participants who
had agreed to re-contact were invited to participate in the study again and were 10 to
31 years old at the time of data collection. The current study included participants aged
from seven to 17 years at baseline, which resulted in a total sample of N = 10,960 children.
The majority of participants had physical measures of BP at baseline (n = 10,937). A total of
10,853 subjects from the baseline survey cohort also participated in Wave 2, corresponding
to 61.5% of the participants in the baseline study. In Wave 2, physical examinations were
again performed, in addition to written and oral interviews [42]. For the cohort analysis, BP
and heart rate values were recorded for the second time as follow-up in Wave 2. Physical
examination was offered only to those participants who still lived in the place where they
first participated. In the case of non-participation, only a survey was requested [43]. Due
to this circumstance, only about one fourth of the participants had physical measurements
of BP at the ten-year follow up (n = 2907).
The group-related design and flowchart of our study can be seen in Figure 1.
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Figure 1. Group participants and matching flowchart. Note: * Participants were excluded due to lack of physical measure-
ments of blood pressure at the ten-year follow up. 
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at two recordings by means of an oscillometric measurement using an automatic, digital 
BP monitor (Datascope Accutorr Plus, Mindray DS, Mahwah, NJ, USA). The measure-
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heart and a BP cuff was selected which covered two thirds of the unclothed upper arm of 
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Figure 1. Group participants and matching flowchart. Note: * Participants were excluded due to lack of physical measure-
ments of blood pressure at the ten-year follow up.
2.2. Assessment of ADHD Symptoms
Participants were included in the group of confirmed ADHD cases if a corresponding
pre-diagnosis, at that time in Germany on the basis of the International Classification of
Diseases 10 (ICD-10)/Diagnostic and Statistical Manual of Mental Disorders 4 (DSM-4)),
given by either a physician or psychologist, had been reported by the parents at the begin-
ni g of the study inclusio (n = 603, 5.5%). Participants with a score of equal to or greater
than seven on the hyperactivity/inattention subsc le of the Strengths and Difficulties
Questionnaire (SDQ) were classified as suspected ca es (n = 888, 8.10%) [36,38,44]. The
SDQ is a short questionnaire covering the most important areas of psychopathology in
children and adolescents. It consists of 25 items, which can be assigned to five subscales:
emotional problems, behavioral problems, hyperactivity, peer problems, and prosocial
behavior [45,46]. The SDQ dysregulation profile describes a combination of SDQ items in
terms of a broader, dimensional, psychopathological concept [47]. In our analysis, study
participants with diagnosed ADHD or suspected ADHD (SDQ hyperactivity/inattention
subscale score ≥ 7) were combined in the ADHD risk group (n = 1219, 11.1%, including
n = 272 children iagnosed with both ADHD and SDQ ≥ 7), while n = 9741 (88.9%) subjec s
were considered as non-ADHD controls.
2.3. Blood Pressure and Heart Rate Measurements
In all participants in the KiGGS study aged between three and 17 years, systolic and
diastolic BP recordings, as well as arterial mean pressure and heart rate were determined at
two recordings by means of an oscillometric measurement using an automatic, digital BP
mo itor (Datascope Accutorr Plus, Mindray DS, Mah ah, NJ, USA). The measurements
were performed o the right arm, the subject in a seated position, having rest d for five
and s ven minutes, respectively. The right elbow was positioned at the level of the heart
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and a BP cuff was selected which covered two thirds of the unclothed upper arm of the
proband [48].
2.4. Statistical Analysis
Demographic characteristics as well as laboratory measurements of eligible partic-
ipants were firstly examined in a descriptive manner with numerical data expressed as
means and standard deviations, and categorical data expressed as frequencies and per-
centages. The differences between individuals in the ADHD and control group were
compared using chi-square tests for categorical variables and t-tests for continuous vari-
ables. Propensity score matching was used to improve the comparability between the
ADHD and control group. The propensity score matching approximates the counterfactual
scenario by creating statistically matched groups of individuals that differ solely in their
classification to the ADHD group, while the observed covariates/confounders were kept
similar [49]. The propensity score for each individual was generated through a model
predicting the risk of classification to the ADHD group, and this score was then used to
match the two groups. The exposed group was matched with varying numbers of controls,
where the smaller the number (e.g., one-to-one matching), the smaller the propensity-score
distance and less bias. In this analysis, we used the commonly employed matching method
of the nearest neighbor matching, where for each participant in the ADHD group, the
participant with the closest propensity score (i.e., the smallest distance) was found in
the control group, while the non-selected controls were discarded. The distributions of
ADHD propensity for individuals in the ADHD and the control group before and after
matching were presented in bar charts. After the comparable ADHD and control groups
were established (herein referred as the matched sample), we tested the predictive value
of BP indicators on ADHD using logistic regression models. For each potential predictor,
including the BP indicators (systolic, diastolic, and pulse pressure) as well as demographic
(age, sex, socioeconomic status) and laboratory measurements (body-mass index (BMI),
heart rate), a univariate logistic regression (i.e., the unadjusted model) was conducted to
test whether it predicted ADHD (i.e., individual’s group membership in the ADHD vs.
control groups). For each BP indicator, a multivariate logistic regression model was created,
the demographic and laboratory measurements (i.e., the adjusted model) being controlled.
Individuals in the matched sample were followed over ten years (herein referred as the
followed-and-matched sample). Descriptive comparisons on measurements at baseline,
follow-up, as well as changes from baseline to follow-up were reported. Multivariate logis-
tic regressions were conducted in the followed-and-matched sample to test the predictive
value of BP indicators at (a) baseline to test the sensitivity of the relationship due to sample
shrinkage and (b) follow-up to study the persistence of the relationship in the course of a
longitudinal development. All statistical analyses were performed in R version 3.6.1 [50]
and statistical significance was defined as p < 0.05 in all tests. Effect sizes were calculated
in the form of Cohen’s d for t-tests, Cohen’s ω for chi-square tests, and odds ratios/Exp (ß)
for logistic regressions. As sensitivity analysis, we compared participants in the control
group and participants with more stringent ADHD, namely who fulfilled both criteria
of pre-diagnosed ADHD and SDQ-H ≥ 7, to strengthen our findings (see addendum in
Supplementary Material).
3. Results
3.1. Characterization of the KiGGS Baseline Cohort
Among the total KiGGS study cohort aged 7 to 17 years (N = 10,960), there were
n = 603 (5.5%) participants diagnosed as suffering from ADHD by a clinician or psycholo-
gist, and n = 888 (8.1%) participants fell into the suspected ADHD category with their score
from the SDQ hyperactivity-inattention subscale ≥ 7. The diagnosed ADHD and suspected
ADHD group together consisted of the ADHD risk group in the current study (n = 1219,
11.1%, including n = 272 children with both diagnosed and suspected ADHD), while the
rest of the participants (n = 9741, 88.9%) were considered as the control group. As shown
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in the left panel of Table 1, compared with participants from the control group, those in the
ADHD group were younger (t(10958) = −6.997, p < 0.001, Cohen’s d = 0.21), less likely to be
female (χ2 (1, N = 10960) = 264.440, p < 0.001, Cohen’s ω = 0.16), from lower socioeconomic
background (t(10651) = −9.528, p < 0.001, Cohen’s d = 0.29), have lower body-mass index
(t(10908) = −2.676, p < 0.001, Cohen’s d = 0.08), and similar level of average heart rate
(t(10905) = −0.408, p = 0.683, Cohen’s d = 0.01). The upper panel of Figure 2 presents
the distribution of participants’ propensity scores of ADHD risks based on the indicators.
The 9741 participants in the control group showed a skewed distribution compared to
the more normally distributed 1219 participants from the ADHD group. To improve the
comparability of the ADHD group and control group in observed confounders, participants
in the ADHD and control group were compared using propensity score matching with the
nearest neighbor matching technique. The matched sample included 1190 participants from
the ADHD group and the same number of participants from the control group with the
closest propensity of ADHD risks. As shown in the right panel of Table 1, after matching,
participants in the ADHD group were similar to participants from the control group in
age (t(2378) = −0.137, p = 0.891, Cohen’s d = 0.01), sex ratio (χ2 (1, N = 2380) = 0.002,
p = 0.963, Cohen’s ω = 0.002), socioeconomic background (t(2378) = −0.108, p = 0.912,
Cohen’s d = 0.004), body-mass index (t(2378) = −0.253, p = 0.800, Cohen’s d = 0.01), and
heart rate (t(2378) = 0.575, p = 0.565, Cohen’s d = 0.02). The distributions of the participants’
propensity scores for ADHD risks after matching are presented in the bottom panel of
Figure 2. The distribution of the control group after matching approached normality and
was similar to the distribution of the ADHD group, showing that the propensity score
matching corrected for the confounding factors to a large extent.
Table 1. Characterization of participants in the ADHD and control group at German Health Interview and Examination
Survey for Children and Adolescents (KiGGS) baseline (before and after matching).
Variable








Control Group p Value
(n = 1219) (n = 9741) (n = 1190) (n = 1190)
Age (years) 11.25 ± 2.91 11.92 ± 3.13 <0.001 11.26 ± 2.92 11.27 ± 3.07 0.891
Sex (%)
Female 26.74 51.48 <0.001 26.81 26.64 0.963
SDQ-H 6.99 ± 1.90 2.54 ± 1.79 <0.001 6.97 ± 1.91 2.80± 1.81 <0.001
SES Winkler index 10.32 ± 4.16 11.58 ± 4.33 <0.001 10.33 ± 4.17 10.35 ± 4.17 0.912




0.907Medium 46.61 47.62 46.47 46.05
High 16.22 26.25 16.3 16.97
BMI (kg/m2) 19.28 ± 4.20 19.61 ± 4.00 0.007 19.26 ± 4.19 19.31 ± 3.94 0.8
BMI Category (%)




Normal (18.5 ≤ BMI < 25.0) 38.97 45.92 39.08 40.67
Overweight (25.0 ≤ BMI < 30.0) 8.04 7.31 8.15 7.9
Obese (BMI > 30.0) 2.46 2.68 1.76 1.43
Heart rate (bpm) 78.61 ± 11.73 78.47 ± 11.78 0.683 78.54 ± 23.30 78.26 ±11.63 0.565
Systolic BP (mmHg) 107.71 ± 10.69 110.55 ± 11.22 <0.001 107.6 ± 10.66 109.49 ± 10.89 <0.001
Diastolic BP (mmHg) 64.65 ± 7.52 66.39 ± 7.58 <0.001 64.57 ± 7.48 65.75 ± 7.44 <0.001
Pulse pressure (mmHg) 43.06 ± 7.81 44.15 ±7.92 <0.001 43.03 ± 7.78 43.73 ± 7.89 0.028
Note: Bpm = beats per minute; BMI = body-mass index; mmHg = millimeters of mercury; SDQ-H = hyperactivity-inattention subscale of
the Strengths and Difficulties Questionnaire; SES = socioeconomic status; pulse pressure = the difference between systolic blood pressure
and diastolic blood pressure.
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3.2. Blood Pressure in the KiGGS Baseline Cohort
In the KiGGS baseline cohort of 10,960 participants, systolic and diastolic BP, as well
as the pulse pressure were all significantly lower among participants in the ADHD
group as compared with those in the control group (before matching: for systolic BP,
t(10935) = −8.349, p < 0.001, Cohen’s d = 0.25; for diastolic BP, t(10935) = −7.572, p < 0.001,
Cohen’s d = 0.23; for pulse pressure, t(10935) = −4.533, p < 0.001, Cohen’s d = 0.14,
Table 1 left panel; and after matching: for systolic BP, t(1190) = −4.267, p < 0.001, Cohen’s
d = 0.17; for diastolic BP, t(1190) = −3.859, p < 0.001, Cohen’s d = 0.16; for pulse pressure,
t(1190) = −2.192, p = 0.028, Cohen’s d = 0.09, Table 1 right panel). Results from univariate
logistic regression analyses in the upper left panel of Table 2 showed that without adjust-
ment for confounding variables, all hemodynamic parameters tested, namely systolic BP,
diastolic BP, and pulse pressure, were significantly associated with ADHD. In the multivari-
ate logistic models shown in the bottom left panel of Table 2, the associations between BP
and ADHD were tested with age, sex, socioeconomic status, body-mass index, and heart
rate controlled. The systolic BP (exp(ß) = 0.968, 95%-CI 0.961–0.975, p < 0.001), diastolic BP
(exp(ß) = 0.969, 95%-CI 0.960–0.978, p < 0.001), and pulse pressure (exp(ß) = 0.983, 95%-CI
0.974–0.992, p < 0.001) were all independently and significantly associated with ADHD in
separate models. In the matched sample of 2380 participants, the differences in systolic and
diastolic BP, as well as the pulse pressure, among participants in the ADHD and control
group were smaller but remained statistically significant (for systolic BP, exp(ß) = 0.984,
95%-CI 0.976–0.991, p < 0.001; for diastolic BP, exp(ß) = 0.979, 95%-CI 0.968–0.990, p < 0.001;
for pulse pressure, exp(ß) = 0.989, 95%-CI 0.978–0.999, p = 0.029, Table 2 right panel). Simi-
larly, the multivariate logistic regression showed consistent reverse associations between
ADHD and the systolic BP (exp(ß) = 0.971, 95%-CI 0.961–0.981, p < 0.001), diastolic BP
(exp(ß) = 0.973, 95%-CI 0.961–0.985, p < 0.001), and pulse pressure (exp(ß) = 0.985, 95%-CI
0.973–0.997, p = 0.016), whereas the majority of the confounders were no longer significantly
associated with ADHD.
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Table 2. Results from unadjusted and adjusted logistic regression models with ADHD as dependent variable in the KiGGS
baseline cohort (before and after matching). Unadjusted models used univariate logistic regression. Adjusted models used
multivariate logistic regression with systolic, diastolic blood pressure, or pulse pressure as independent variables, adjusted
for age, sex, socioeconomic status, body-mass index, and heart rate.
Variable
Before Matching (n = 10,960) After Matching (n = 2380)
Exp (ß) 95%-CI Wald p Value Exp (ß) 95%-CI Wald p Value
Unadjusted Models
Age 0.933 0.915–0.952 −6.953 <0.001 0.998 0.972–1.025 −0.137 0.891
Sex 0.344 0.301–0.393 −15.74 <0.001 1.009 0.841–1.209 0.093 0.926
SES 0.932 0.919–0.946 −9.423 <0.001 0.999 0.98–1.018 −0.108 0.914
BMI 0.979 0.964–0.994 −2.674 0.007 0.997 0.978–1.017 −0.253 0.8
Heart rate 1.001 0.996–1.006 0.408 0.683 1.002 0.995–1.009 0.575 0.565
Systolic BP 0.976 0.971–0.982 −8.3 <0.001 0.984 0.976–0.991 −4.233 <0.001
Diastolic BP 0.969 0.962–0.977 −7.539 <0.001 0.979 0.968–0.990 −3.836 <0.001
Pulse
pressure 0.982 0.975–0.990 −4.526 <0.001 0.989 0.978–0.999 −2.188 0.029
Adjusted Model for Systolic BP
Age 0.986 0.960–1.014 −0.967 0.333 1.053 1.015–1.093 2.772 0.006
Sex 0.318 0.277–0.365 −16.329 <0.001 0.955 0.794–1.148 −0.491 0.623
SES 0.93 0.916–0.944 −9.465 <0.001 0.998 0.979–1.018 −0.174 0.862
BMI 1.03 1.011–1.050 3.073 0.002 1.023 0.998–1.049 1.826 0.068
Heart rate 1.004 0.998–1.010 1.252 0.211 1.007 0.999–1.014 1.75 0.08
Systolic BP 0.968 0.961–0.975 −8.259 <0.001 0.971 0.961–0.981 −5.624 <0.001
Adjusted Model for Diastolic BP
Age 0.961 0.936–0.986 −3.021 0.003 1.027 0.993–1.063 1.534 0.125
Sex 0.333 0.291–0.382 −15.777 <0.001 0.987 0.821–1.186 −0.14 0.888
SES 0.929 0.915–0.943 −9.588 <0.001 0.999 0.979–1.018 −0.136 0.892
BMI 1.011 0.993–1.029 1.168 0.243 1.005 0.982–1.029 0.451 0.652
Heart rate 1.003 0.997–1.009 1.057 0.291 1.006 0.999–1.014 1.646 0.1
Diastolic BP 0.969 0.960–0.978 −6.539 <0.001 0.973 0.961–0.985 −4.368 <0.001
Adjusted Model for Pulse Pressure
Age 0.948 0.924–0.972 −4.121 <0.001 1.015 0.981–1.049 0.841 0.401
Sex 0.333 0.291–0.382 −15.768 <0.001 0.988 0.823–1.187 −0.128 0.898
SES 0.929 0.916–0.944 −9.481 <0.001 0.999 0.979–1.019 −0.119 0.905
BMI 1.01 0.991–1.029 1.031 0.303 1.005 0.982–1.03 0.448 0.654
Heart rate 0.998 0.993–1.004 −0.656 0.512 1.002 0.995–1.009 0.568 0.57
Pulse
pressure 0.983 0.974–0.992 −3.747 <0.001 0.985 0.973–0.997 −2.422 0.016
Abbreviations: BMI = Body-mass index; BP = blood pressure; CI = confidence intervals; SES = socioeconomic status.
3.3. The Matched Sample at KiGGS Follow-Up
About one-fourth of participants (n = 596; aged 18–24 years) of the matched sample
had BP measurements taken at KiGGS follow-up ten years later. The upper panel of Table 3
shows the 596 participants’ characteristics at baseline according to their classification into
the ADHD or control group at baseline. The ADHD and control group remained to be
comparable, reflected by the similar level of confounding variables at baseline, including
age (t(594) = 0.153, p = 0.879, Cohen’s d = 0.01), sex ratio (χ2 (1, N = 596) = 0.610, p = 0.435,
Cohen’s ω = 0.04), socioeconomic status (t(594) = 0.950, p = 0.342, Cohen’s d = 0.08),
body-mass index (t(594) = 0.407, p = 0.684, Cohen’s d = 0.3), and heart rate (t(594) = 1.146,
p = 0.252, Cohen’s d = 0.15). At follow-up, the differences in systolic and diastolic BP,
as well as the pulse pressure among those participants in the ADHD and control group
were no longer significant at the descriptive level (for systolic BP, t(594) = −1.811, p = 0.071,
Cohen’s d = 0.15; for diastolic BP, t(594) = −1.927, p = 0.055, Cohen’s d = 0.16; for pulse
pressure, t(594) = −0.646, p = 0.519, Cohen’s d = 0.05). In contrast, the baseline results of this
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reduced sample size (left panel of Table 4) showed that the associations between systolic
BP (exp(ß) = 0.969, 95%-CI 0.949–0.991, p = 0.005) and diastolic BP (exp(ß) = 0.967, 95%-CI
0.942–0.992, p = 0.009), respectively, and ADHD were significant when the confounders
were controlled for. Hence, the associations at baseline remained significant regardless of
sample size shrinkage due to technical matching or follow-up measurement (n = 10,960
vs. n = 2380 vs. n = 596), suggesting the reverse relationships between ADHD and systolic
or diastolic BP, but not pulse pressure, at a younger age. The middle and bottom panels
of Table 3 showed the measurements at follow-up as well as the difference between those
measurements at baseline vs. follow-up. Body-mass index and BP experienced an increase
during the ten-year period, while the heart rate decreased. Participants in the ADHD
and control group had similar levels for all those measurements, except for a significantly
elevated level and change in body-mass index after ten years for the ADHD group. As is
shown in the right panel of Table 4 (i.e., follow-up), even after having been controlled for
confounders in the multivariate logistic regression models, the associations between ADHD
and systolic BP (exp(ß) = 0.992, 95%-CI 0.975–1.009, p = 0.337), diastolic BP (exp(ß) = 0.993,
95%-CI 0.968–1.018, p = 0.567) and pulse pressure (exp(ß) = 0.991, 95%-CI 0.968–1.014,
p = 0.423) were all not significant. However, there might be a tendency to a somewhat
higher heart rate in ADHD at follow-up.
Table 3. Characterization of matched participants in the ADHD and control group at KiGGS follow-up.
Variable
Participants in the ADHD Group Participants in the Control Group p Value
(n = 273) (n = 323)
Measurement at Baseline
Age (years) 10.60 ± 2.93 10.56 ± 2.99 0.879
Sex (%)
Female 28.57 25.39 0.435
SDQ-H 6.97 ± 1.93 2.74 ± 1.82 <0.001
SES Winkler index 10.97 ± 3.98 10.65 ± 4.13 0.342




BMI (kg/m2) 18.59 ± 4.11 18.46 ± 3.56 0.684
BMI Category (%)
Underweight (BMI < 18.5) 61.9 60.06
0.425
Normal (18.5 ≤ BMI < 25.0) 30.77 33.44
Overweight (25.0 ≤ BMI < 30.0) 5.86 6.19
Obese (BMI > 30.0) 1.47 0.31
Heart rate (bpm) 80.00 ± 11.34 78.96 ± 10.93 0.252
Systolic BP (mmHg) 106.14 ± 10.74 107.73 ± 10.69 0.071
Diastolic BP (mmHg) 63.8 ± 7.59 64.99 ± 7.44 0.055
Pulse pressure (mmHg) 42.34 ± 7.32 42.74 ± 7.91 0.519
Measurement at Follow-Up
Age (years) 21.53 ± 2.92 21.48 ± 3.04 0.856
BMI at (kg/m2) 24.81 ± 5.40 23.86 ± 4.02 0.014
BMI Category (%)
Underweight (BMI < 18.5) 4.76 5.26
0.017
Normal (18.5 ≤ BMI < 25.0) 56.41 60.37
Overweight (25.0 ≤ BMI < 30.0) 22.34 26.32
Obese (BMI > 30.0) 16.48 8.05
Heart rate (bpm) 75.46 ± 12.93 73.55 ± 11.80 0.06
Systolic BP (mmHg) 123.4 ± 10.65 123.78 ± 11.1 0.675
Diastolic BP (mmHg) 71.86 ± 6.84 71.85 ± 7.06 0.992
Pulse pressure (mmHg) 51.55 ± 7.86 51.93 ± 8.05 0.561
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Table 3. Cont.
Variable
Participants in the ADHD Group Participants in the Control Group p Value
(n = 273) (n = 323)
Baseline vs. Follow-Up Change
BMI at (kg/m2) 6.22 ± 3.9.0 5.41 ± 3.22 0.006
Heart rate (bpm) −4.54 ± 13.04 −5.41 ± 13.37 0.427
Systolic BP (mmHg) 17.27 ± 11.44 16.05 ± 12.73 0.223
Diastolic BP (mmHg) 8.05 ± 8.00 6.86 ± 8.65 0.083
Pulse pressure (mmHg) 9.21 ± 9.81 9.19 ± 10.45 0.976
Abbreviations: BMI = body-mass index; BP = blood pressure; bpm = beats per minute; mmHg = millimeters of mercury; SDQ-H =
hyperactivity-inattention subscale of the Strengths and Difficulties Questionnaire; SES = socioeconomic status; pulse pressure = the
difference between systolic blood pressure and diastolic blood pressure.
Table 4. Results from adjusted logistic regression models with ADHD as dependent variable in the matched sample retained
at KiGGS follow-up. Adjusted models used multivariate logistic regression with systolic, diastolic blood pressure or pulse
pressure at baseline or follow-up as independent variables, adjusted for age, sex, socioeconomic status, as well as body-mass
index and heart rate at corresponding time points.
BP at Baseline (n =596) BP at Follow-Up (n =596) Baseline vs. Follow-Up Change (n = 596)
Exp
(ß) 95%-CI Wald p Value
Exp
(ß) 95%-CI Wald p Value
Exp
(ß) 95%-CI Wald p Value
Adjusted Model for Systolic BP at Baseline or Follow-Up
Age 1.065 0.987–1.149 1.624 0.104 Age 1.004 0.949–1.063 0.145 0.885 1.024 0.962–1.091 0.749 0.454
Sex 1.118 0.771–1.621 0.586 0.558 Sex 1.065 0.709–1.599 0.302 0.763 1.271 0.853–1.894 1.179 0.239
SES 1.017 0.977–1.060 0.837 0.403 SES 1.027 0.986–1.069 1.261 0.207 1.024 0.983–1.067 1.129 0.259
BMI at
baseline 1.039 0.985–1.096 1.4 0.161
BMI at
follow-up 1.053 1.015–1.093 2.751 0.006 1.05 1.013–1.090 2.65 0.008
Heart rate
at baseline 1.014 0.998–1.030 1.687 0.092
Heart rate at




0.969 0.949–0.991 −2.83 0.005 Systolic BPat follow-up 0.992 0.975–1.009 −0.959 0.337 1.013 0.997–1.029 1.602 0.109
Adjusted Model for Diastolic BP at Baseline or Follow-Up
Age 1.046 0.973–1.123 1.221 0.222 Age 1.005 0.949–1.065 0.169 0.865 1.012 0.956–1.072 0.419 0.675
Sex 1.129 0.779–1.635 0.639 0.523 Sex 1.128 0.770–1.652 0.619 0.536 1.17 0.801–1.709 0.813 0.416
SES 1.022 0.981–1.064 1.053 0.292 SES 1.026 0.985–1.069 1.256 0.209 1.026 0.985–1.069 1.221 0.222
BMI at
baseline 1.021 0.971–1.074 0.805 0.421
BMI at
follow-up 1.05 1.012–1.089 2.629 0.009 1.053 1.016–1.093 2.774 0.006
Heart rate
at baseline 1.015 0.999–1.031 1.814 0.07
Heart rate at




0.967 0.942–0.992 −2.604 0.009 Diastolic BPat follow-up 0.993 0.968–1.018 −0.572 0.567 1.02 0.999–1.041 1.878 0.06
Adjusted Model for Pulse Pressure at Baseline or Follow-Up
Age 1.016 0.949–1.088 0.463 0.644 Age 1 0.945–1.058 −0.004 0.997 1.003 0.944–1.065 0.101 0.919
Sex 1.174 0.812–1.696 0.854 0.393 Sex 1.076 0.715–1.619 0.351 0.726 1.16 0.779–1.726 0.731 0.465
SES 1.022 0.981–1.064 1.04 0.299 SES 1.027 0.986–1.069 1.263 0.207 1.026 0.985–1.069 1.241 0.214
BMI at
baseline 1.016 0.965–1.070 0.613 0.54
BMI at
follow-up 1.054 1.015–1.094 2.732 0.006 1.049 1.013–1.089 2.605 0.009
Heart rate
at baseline 1.009 0.994–1.024 1.134 0.257
Heart rate at








0.991 0.968–1.014 −0.801 0.423 1.002 0.984–1.020 0.167 0.868
Abbreviations: see Table 1.
3.4. Sensitivity Analysis with Stringent ADHD Criteria
In comparison to the calculation described in Section 3.1, in the sensitivity anal-
ysis (flowchart, see Figure S1) with more stringent ADHD criteria from the total co-
hort (N = 10,960), the ADHD suspected group (n = 947, 8.6%), which had either only
an SDQ-H ≥ 7, or only an ADHD prediagnosis, was excluded and only the cases with
both characteristics were considered (n = 272, 2.5%). The control group (n = 9741, 88.8%)
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remained the same. Again in this calculation, systolic and diastolic BP and pulse pressure
were significantly lower in participants in the ADHD group compared with the control
group at baseline (before matching: for systolic BP, t(9990) = 5.0016, p < 0.001, Cohen’s d
= 0.31; for diastolic BP, t(9990) = 3.9492, p < 0. 001, Cohen’s d = 0.24; for pulse pressure,
t(9990) = 3.2898, p = 0.001, Cohen’s d = 0.20 (Table S1 left panel)). After matching more
comparable participants with stringent ADHD and controls, the group differences on BP
measures remained despite the vast shrinkage in sample size (for systolic BP, t(527) = 2.9068,
p = 0.003, Cohen’s d = 0.25; for diastolic BP, t(527) = 3.1451, p = 0.001, Cohen’s d = 0.27;
for pulse pressure, t(527) = 1.1904, p = 0.234, Cohen’s d = 0.10 (Table S1 right panel)).
Regarding distributions of the participants’ propensity scores for ADHD risks before and
after matching, see Supplementary Figure S1. In the matched sample of 530 participants,
the differences in systolic and diastolic BP among participants in the ADHD and control
group remained stable (for systolic BP, exp(ß) = 0.977 95%-CI 0.962–0.993, p = 0.004; for
diastolic BP, exp(ß) = 0.963, 95%-CI 0.939–0.986, p = 0.002; for pulse pressure, exp(ß) = 0.987,
95%-CI 0.966–1.008, p = 0.234, Table S2 right panel). In the multivariate logistic regres-
sion, reverse associations between ADHD and the systolic BP (exp(ß) = 0.951, 95%-CI
0.930–0.971, p < 0.001) and the diastolic BP (exp(ß) = 0.948, 95%-CI 0.923–0.974, p < 0.001)
were observed (Table S2 right panel). In the follow-up study, only n = 58 participants (0.5%)
in the stringent ADHD group and n = 73 participants (0.67%) in the control group had
available BP measures. Among this small subsample, we could not detect any significant
difference in BP between participants in the stringent ADHD and control groups, as shown
in Tables S3 and S4.
4. Discussion
When children with ADHD are treated with stimulants, they often show an increase
of their usually low BP concurrently with symptom improvement [51–54]. This clinical
observation and additional findings from diurnal heart rate, cortisol level and sleep stages
suggest a dysregulation of the autonomic nervous system in children with ADHD and
leads to the subcortical (low) arousal hypothesis. Hence, in this post-hoc analysis, the
naturalistic data from the nationwide representative KiGGS study were used to test the
arousal hypothesis with regard to BP regulation in children with ADHD aged between 7
and 17 years. In an earlier cross-sectional study from the KiGGS baseline cohort, ADHD
was significantly associated with lower BP [37]. In order to extend and deepen this finding,
KiGGS baseline and Wave 2 data from a different age distribution were compared between
youngsters with vs. without ADHD including at Wave 2 longitudinal data of a ten-year
follow-up assessment, adding a developmental perspective.
Even after broadening the age spectrum to 7 to 17 years, and therefore including a
larger sample size (n = 9741 controls, n = 1219 ADHD) compared to our previous study [37]
(n = 1219 controls vs. n = 667 ADHD), it was shown that systolic and diastolic BP record-
ings within the ADHD group were significantly below the corresponding values from
the non-ADHD control group at baseline, whereas heart rate was similar. In order to
improve the comparability of the two groups, we also used an additional statistical tool,
namely the propensity score matching technique. The results from this statistical approach
demonstrated that systolic and diastolic BP recordings were significantly lower in ADHD
patients compared with non-ADHD controls both before and after matching. These find-
ings were observed in both univariate models and multivariate models with age, gender,
socioeconomic status, and BMI as confounders and were strengthened by similar results of
an additional sensitivity analysis with more stringent ADHD criteria and a smaller ADHD
group size (n = 272). Thus, according to the arousal hypothesis, the lower BP in ADHD
should indicate a subcortical hypoarousal of their brain [26,55]. It is assumed that the symp-
toms of hyperactivity and sensation seeking, which are typical in ADHD, may represent a
behavioral compensatory approach to equalize this state of hypoarousal [28,56,57].
It is noteworthy that the differences between ADHD and controls on systolic and
diastolic BP were of high statistical significance (p < 0.001), but only of small effect sizes.
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The slight decrease of effect sizes after matching suggests that findings on autonomic
arousal in ADHD, which did not thoroughly consider confounders, should be interpreted
with caution.
Significantly low systolic and diastolic BP values for ADHD at baseline could be
revealed even after strongly matching the two samples, remaining with small effect sizes of
Cohen’s d = 0.17 and Cohen’s d = 0.16, respectively. However, when more stringent ADHD
criteria were applied, in a sensitivity analysis the values for Cohen’s d were 0.25 and 0.27,
respectively, for a smaller matched sample. Whether this might mean that subcortical
hypoarousal is merely expressed in more severe ADHD remains to be investigated. The
small effect sizes are not a real surprise for subcortical parameters as can be seen from a
large-scale (n = 1713 ADHD, n = 1529 controls) cross-sectional meta-analysis of magnetic
resonance imaging (MRI)-based brain volume differences comparing children and adults
with vs. without ADHD. There were significantly smaller volumes in children (below
the age of 15 years) with ADHD but not in adults with ADHD. Thus, they extended the
brain maturation delay theory for ADHD to include subcortical regions [58]. For their
data of children, the authors reported small effect sizes (e.g., nucleus accumbens Cohen’s
d = −0.19, amygdala Cohen’s d = −0.18, caudate Cohen’s d = −0.13), probably suggesting
that multiple small subcortical deviations within the autonomic nervous system might
contribute to the hypoarousal in ADHD. Since brain structure and function are closely
related, our findings with a low BP (reflecting low subcortical arousal) in children with
ADHD are in line with the view of subcortical neuronal deviations in ADHD. It has to
be added that well-grounded models of fronto-striatal dysfunction in ADHD (including
deviations of cortical activation patterns, as in Rodríguez et al. [22]) are closely related
to cortical structures, which may play a more important role in the severity of ADHD
symptoms than the (interacting) subcortical ones [58].
In contrast to the findings within the larger cohort at baseline, within the smaller
ten-year follow-up cohort, no significant difference for BP could be observed. This change
is not entirely due to the shrinking of the sample size, as we could replicate the association
between ADHD and lower BP at baseline measurement within the smaller cohort. The
lack of follow-up differences might be due to brain maturational effects. The much lower
number of BP values available might have played a minor role, since the similar small
sample size of ADHD at baseline still showed up with significant differences of BP. Given
the higher age of the participants at follow-up, BMI and BP increased during the ten-year
period. Even after checking for confounders in the multivariate logistic regression models,
the associations between systolic and diastolic BP and ADHD were no longer significant
at follow-up and thus a model of subcortical maturational delay might be applied as in
Hoogman et al. [58].
Probably, the increase of the BP values at the follow-up examination of this study
may reflect that the hypoarousal hypothesis (valid for children; also verified with other
measures of autonomous arousal [30–33]) no longer holds true for the adolescent and
young adult group. An explanation could be the developmental improvement of frontally
related compensatory neuronal circuits and/or the recovering of usually more general
maturational processes with age in ADHD during late adolescence and young adulthood,
at least in cases with a decrease in ADHD symptomatology over time [59–61].
A strength of our population study was the large and representative sample size,
as well as the possibility of longitudinal observation. Furthermore, propensity score
matching enabled a higher comparability of the participants with and without ADHD
and an additional sensitivity analysis underlined the robustness of our findings. As a
limitation, it must be mentioned that it was not possible to include data on drug treatment
of the participants. On the other hand, stimulants, as the standard medication for ADHD,
could have increased BP and thus having counteracted our hypothesis. ADHD diagnosis at
follow-up was not available. Due to the lack of BP values in the majority of the participants,
there was a substantial reduction in sample size at the time of follow-up.
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5. Conclusions
In summary, significant differences of small effect sizes were found in BP recordings
between children with vs. without clinical signs of ADHD, but these differences seem to
disappear in young adulthood. Our analysis demonstrated that hemodynamic param-
eters should be considered to better understand the pathophysiology of ADHD in the
developmental context of the subcortical arousal hypothesis.
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601/18/4/1864/s1, Table S1: Characterization of participants in the stringent ADHD and control
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(before and after matching). Table S3: Characterization of matched participants in the stringent
ADHD and control group at KiGGS follow-up. Table S4: Results from adjusted logistic regression
models with stringent ADHD as dependent variable in the matched sample retained at KiGGS
follow-up. Figure S1: Distribution of the propensity score for ADHD (before and after matching).
Figure S2: Group participants and matching flowchart.
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